Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
ISSN: 2155-9570
Michel Marco P Figueras
Cardinal Santos Medical Center, Philippines
Posters & Accepted Abstracts: J Clin Exp Ophthalmol
This is a case of a 22-year-old female from the Philippines with a chief complaint of blurring of vision who developed choroidal neovascular membrane with central retinopathy. The patient had history of anti-psychotropic oral medications use for 1 year duration (Escitalopram, Quetiapine, Clonazepam and Alprazolam). She was diagnosed with major depressive disorder 1 year prior and presented on the day of consult with sudden blurring of vision of the left eye. Best corrected vision was 20/20 on the right eye and 20/70 on the left eye. Fundus exam revealed a surface elevation in the foveal area. Fluorescein angiography and ocular coherence tomography read as central serous retinopathy. However, further examination after 15 days on OCT revealed a choroidal neo-vascular membrane developing. Aflibercept injection 0.4 ml was injected once a month for 3 doses. Patient improved to 20/30 on the affected eye thereafter. Central serous choriorioretinopathy is characterized by sudden unilateral blurring of vision. Histologically, neurosensory detachments and/or retinal pigment detachments can be seen mostly confined in the macula and is said to have occurred because of leakage of fluid to the sub-retinal spaces. Management includes careful observation in most cases. However, there is no protocol in management of atypical CSR secondary to anti depressive medication overdose. We propose that because membranes are irreversible, patients who develop an atypical case of central serous chorioretinopathy due to antipsychotic drugs need a protocol for monitoring, and if needed, anti VEGF treatment 0.4 ml every month was effective in this case.
E-mail: marcofigueras@yahoo.com